Effect of TNFα and RELA inhibition on gene expression in human PDAC cells
Single-cell RNA-seq · human · 28 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Homo sapiens (human)
- Topic
- Pancreatic cancerThis series is part of our curated briefing on it.
- Samples
- 28 samples: 28 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Actin networks modulate heterogeneous NF-κB dynamics in response to TNFαeLife · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE268743_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1118415 and SRA study SRP510931. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 28 sample titles: 28 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8298264 MIA PaCa2 cells, 1 hr DMSO treatment
- GSM8298265 MIA PaCa2 cells, 5 hr DMSO treatment
- GSM8298266 MIA PaCa2 cells, 1 hr 0.01 ng/ml TNF treatment
- GSM8298267 MIA PaCa2 cells, 5 hr 0.01 ng/ml TNF treatment
- GSM8298268 MIA PaCa2 cells, 1 hr 0.1 ng/ml TNF treatment
- GSM8298269 MIA PaCa2 cells, 5 hr 0.1 ng/ml TNF treatment
- GSM8298270 MIA PaCa2 cells, 1 hr 10 ng/ml TNF treatment
- GSM8298271 MIA PaCa2 cells, 5 hr 10 ng/ml TNF treatment
- GSM8298272 MIA PaCa2 cells, 1 hr DMSO + 1 µg/ml dox treatment
- GSM8298273 MIA PaCa2 cells, 5 hr DMSO + 1 µg/ml dox treatment
- GSM8298274 MIA PaCa2 cells, 1 hr 0.1 ng/ml TNF + 1 µg/ml dox treatment
- GSM8298275 MIA PaCa2 cells, 5 hr 0.1 ng/ml TNF + 1 µg/ml dox treatment
- GSM8298276 MIA PaCa2 cells, 1 hr 10 ng/ml TNF + 1 µg/ml dox treatment
- GSM8298277 MIA PaCa2 cells, 5 hr 10 ng/ml TNF + 1 µg/ml dox treatment
- GSM8298278 PANC1 cells, 1 hr DMSO treatment
- GSM8298279 PANC1 cells, 5 hr DMSO treatment
- GSM8298280 PANC1 cells, 1 hr 0.01 ng/ml TNF treatment
- GSM8298281 PANC1 cells, 5 hr 0.01 ng/ml TNF treatment
- GSM8298282 PANC1 cells, 1 hr 0.1 ng/ml TNF treatment
- GSM8298283 PANC1 cells, 5 hr 0.1 ng/ml TNF treatment
- GSM8298284 PANC1 cells, 1 hr 10 ng/ml TNF treatment
- GSM8298285 PANC1 cells, 5 hr 10 ng/ml TNF treatment
- GSM8298286 PANC1 cells, 1 hr DMSO + 1 µg/ml dox treatment
- GSM8298287 PANC1 cells, 5 hr DMSO + 1 µg/ml dox treatment
- GSM8298288 PANC1 cells, 1 hr 0.1 ng/ml TNF + 1 µg/ml dox treatment
- GSM8298289 PANC1 cells, 5 hr 0.1 ng/ml TNF + 1 µg/ml dox treatment
- GSM8298290 PANC1 cells, 1 hr 10 ng/ml TNF + 1 µg/ml dox treatment
- GSM8298291 PANC1 cells, 5 hr 10 ng/ml TNF + 1 µg/ml dox treatment
- GSE133979 The muscle and adipose transcriptome data from patients with PDAC cachexia 68 samples same disease briefing · shares pdac
- GSE150043 Deeper insight into Pancreatic Ductal Adenocarcinoma (PDAC) survival heterogeneity using integrative analyses of individual and global transcriptome based networks 19 samples same disease briefing · shares pdac
- GSE101448 Microarray gene-expression data to identify a robust biomarker signature in PDAC and validate it in formalin-fixed paraffin-embedded tissue material. 43 samples same disease briefing · shares pdac
- GSE273492 Selective NSD2 Inhibition Reveals an Epigenetic Vulnerability of KRAS-Driven Cancers [RNA-Seq] 36 samples same disease briefing · shares inhibition
- GSE107818 A serum-induced transcriptome and serum cytokine signature obtained at diagnosis correlates with the development of early pancreatic ductal adenocarcinoma metastasis 11 samples same disease briefing · shares rela
- GSE132946 Tumor Infiltrating Lymphocytes and Immune-Related Genes as Predictors of Outcome in Pancreatic Adenocarcinoma 6 samples same disease briefing · shares rela
- GSE273490 Selective NSD2 Inhibition Reveals an Epigenetic Vulnerability of KRAS-Driven Cancers [CUT&Run] 120 samples same disease briefing · shares inhibition
- GSE273491 Selective NSD2 Inhibition Reveals an Epigenetic Vulnerability of KRAS-Driven Cancers [NicE-seq] 8 samples same disease briefing · shares inhibition
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.